GT200500116A - Derivados de cromanol, un procedimiento para su preparacion y su uso como inhibidores de la inflamacion - Google Patents
Derivados de cromanol, un procedimiento para su preparacion y su uso como inhibidores de la inflamacionInfo
- Publication number
- GT200500116A GT200500116A GT200500116A GT200500116A GT200500116A GT 200500116 A GT200500116 A GT 200500116A GT 200500116 A GT200500116 A GT 200500116A GT 200500116 A GT200500116 A GT 200500116A GT 200500116 A GT200500116 A GT 200500116A
- Authority
- GT
- Guatemala
- Prior art keywords
- procedure
- preparation
- diseases
- inflammation inhibitors
- inflammatory
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004025791A DE102004025791A1 (de) | 2004-05-19 | 2004-05-19 | Chromanol-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200500116A true GT200500116A (es) | 2006-01-24 |
Family
ID=34981469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200500116A GT200500116A (es) | 2004-05-19 | 2005-05-18 | Derivados de cromanol, un procedimiento para su preparacion y su uso como inhibidores de la inflamacion |
Country Status (9)
| Country | Link |
|---|---|
| AR (1) | AR049383A1 (de) |
| DE (1) | DE102004025791A1 (de) |
| GT (1) | GT200500116A (de) |
| PA (1) | PA8633501A1 (de) |
| PE (1) | PE20060313A1 (de) |
| SV (1) | SV2006002119A (de) |
| TW (1) | TW200600510A (de) |
| UY (1) | UY28907A1 (de) |
| WO (1) | WO2005116015A1 (de) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10168095A (ja) * | 1996-12-10 | 1998-06-23 | Cci Corp | 炎症性腸疾患予防および治療剤 |
| MXPA04009329A (es) * | 2002-03-26 | 2005-01-25 | Boehringer Ingelheim Pharma | Mimeticos de glucocorticoides, metodos para su preparacion, composiciones farmaceuticas y usos de los mismos. |
-
2004
- 2004-05-19 DE DE102004025791A patent/DE102004025791A1/de not_active Withdrawn
-
2005
- 2005-04-28 WO PCT/EP2005/004820 patent/WO2005116015A1/de active Search and Examination
- 2005-05-18 UY UY28907A patent/UY28907A1/es not_active Application Discontinuation
- 2005-05-18 AR ARP050102037A patent/AR049383A1/es unknown
- 2005-05-18 GT GT200500116A patent/GT200500116A/es unknown
- 2005-05-18 TW TW094116020A patent/TW200600510A/zh unknown
- 2005-05-18 PE PE2005000548A patent/PE20060313A1/es not_active Application Discontinuation
- 2005-05-19 PA PA20058633501A patent/PA8633501A1/es unknown
- 2005-05-23 SV SV2005002119A patent/SV2006002119A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR049383A1 (es) | 2006-07-26 |
| WO2005116015A1 (de) | 2005-12-08 |
| UY28907A1 (es) | 2005-12-30 |
| PE20060313A1 (es) | 2006-05-25 |
| TW200600510A (en) | 2006-01-01 |
| DE102004025791A1 (de) | 2005-12-15 |
| PA8633501A1 (es) | 2006-07-03 |
| SV2006002119A (es) | 2006-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20140392A (es) | Dihidropirazolonas sustituidas | |
| ECSP077296A (es) | Fenilaminotiazoles sustituidos y su uso | |
| NI200300025A (es) | Derivados de nicotinamida utiles como inhibidores de pde4. | |
| DOP2013000105A (es) | Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogénesis | |
| PA8770101A1 (es) | Amidas de 4-aril-1,4-dihidro-1, 6-naftiridina sustituidas y su uso | |
| ECSP13012668A (es) | Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso | |
| GT200500363A (es) | 3-amino-pirazol [3,4b] piridinas con inhibidores de proteintirosinquinasas, su preparacion y uso como medicamento. | |
| GT200600109A (es) | Derivados de acido pirimidincarboxilico y su uso | |
| CR8649A (es) | Derivados de formamidina para el tratamiento de enfermedades | |
| UY31228A1 (es) | Ariloxazoles sustituidos y su uso | |
| GT200500360A (es) | Compuestos organicos | |
| PA8627001A1 (es) | Compuestos para el tratamiento de enfermedades | |
| CR11684A (es) | Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa | |
| CR20110318A (es) | Compuestos, composición farmacéutica y métodos para utilizarse en el tratamiento de trastornos metabólicos | |
| CU20100111A7 (es) | 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso para el tratamiento y prevención de enfermedades pulmonares y cardiovasculares | |
| PA8661701A1 (es) | Tiazolidinonas, su preparacion y su uso como medicamento | |
| GT200500266A (es) | Nuevos derivados de pirimidina y su uso | |
| UY27657A1 (es) | Derivados de nicotinamida útiles como inhibidores de pde4 | |
| GT200500241A (es) | Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorios | |
| UY30582A1 (es) | Derivados de acido 2-fenoxinicotinico y su uso | |
| CL2008000287A1 (es) | Compuestos derivados de pteridina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar enfermedades inflamatorias y alergicas de las vias respiratorias. | |
| GT200600153A (es) | Derivados de tetrahidronaftalina, procedimientos para su preparación y su uso como antiinflamatorios. | |
| GT200500116A (es) | Derivados de cromanol, un procedimiento para su preparacion y su uso como inhibidores de la inflamacion | |
| SV2005002056A (es) | Derivados de formamida para el tratamiento de enfermedades ref. pc32168a | |
| CR9323A (es) | TIAZOLIDINONAS COMO INHIBIDORAS DE LAS POLOQUINASAS (Plk) COMO MEDICAMENTO |